Subgroup Analyses of Kte-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Adult Patients (Pts) with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in Zuma-3
- Resource Type
- Source
- Transplantation and Cellular Therapy. 29:S7-S8
- Subject
Transplantation Molecular Medicine Immunology and Allergy Cell Biology Hematology - Language
- ISSN
- 2666-6367